SCHEMBL40602

SCHEMBL40602

[C]1=N\N=C/C=C\C=C/1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2691898 0.65
SCHEMBL18321328 0.65
SCHEMBL18460215 0.61
SCHEMBL4449554 0.58
SCHEMBL5050150 0.58
SCHEMBL29380026 0.58
SCHEMBL3395164 0.57
SCHEMBL3395160 0.57
SCHEMBL11473485 0.56
SCHEMBL4437229 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995013808-A1 METHOD FOR SELECTIVELY INHIBITING IL-2 SIGNAL TRANSDUCTION CELL THERAPEUTICS, INC. (US) 1995-05-26 WO claimed
US-20240215579-A1 USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES GULBA DIETRICH (DE) 2024-07-04 US disclosed
CN-118176193-A Nitrogen-containing tetracyclic compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-06-11 CN disclosed
EP-4319556-A1 USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES Gulba, Dietrich (DE) 2024-02-14 EP disclosed
CN-114846012-B 2-isoindole-1, 3, 4-oxadiazole derivatives useful as HDAC6 inhibitors 武田药品工业株式会社 2024-01-26 CN disclosed
US-11702541-B2 Vesicular system and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-07-18 US disclosed
US-11678659-B2 Use as rodenticides of compounds that inhibit blood coagulation GULBA DIETRICH (DE) 2023-06-20 US disclosed
CN-116134038-A IRAK4 inhibitors and topical use thereof 德米拉公司 2023-05-16 CN disclosed
US-10724903-B2 Polymer encapsulated particles as surface enhanced Raman scattering probes NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2020-07-28 US disclosed
US-10464811-B2 Method of forming a particulate porous metal oxide or metalloid oxide NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2019-11-05 US disclosed
US-20020028823-A1 THERAPEUTIC COMPOUNDS FOR INHIBITING INTERLEUKIN-12 SIGNALING AND METHODS FOR USING SAME CELL THERAPEUTICS, INC. 2002-03-07 US disclosed
EP-1171442-A1 XANTHINE DERIVATIVES AND ANALOGS AS CELL SIGNALLING INHIBITORS CELL THERAPEUTICS, INC. (US) 2002-01-16 EP disclosed
WO-2000061583-A1 XANTHINE DERIVATIVES AND ANALOGS AS CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 2000-10-19 WO disclosed
US-5824677-A SUBSTITUTED WITH HETEROCYCLIC RING, ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE CELL THERAPEUTICS, INC. (US) 1998-10-20 US disclosed
US-5777117-A ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE, CYTOTOXIC AGENTS; MICROBIOCIDES, FUNGICIDES CELL THERAPEUTICS, INC. (US) 1998-07-07 US disclosed
US-5750575-A ANTIINFLAMMATORY AGENTS; IMMUNOSUPPRESSANTS; CYTOTOXIC AGENTS; MICROBIOCIDES; FUNGICIDES CELL THERAPEUTICS, INC. (US) 1998-05-12 US disclosed
US-5670507-A Method for reversing multiple drug resistant phenotype CELL THERAPEUTICS, INC. (US) 1997-09-23 US disclosed
US-5641783-A ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS CELL THERAPEUTICS, INC. (US) 1997-06-24 US disclosed
WO-1995013808-A1 METHOD FOR SELECTIVELY INHIBITING IL-2 SIGNAL TRANSDUCTION CELL THERAPEUTICS, INC. (US) 1995-05-26 WO disclosed
EP-0156455-A2 Condensed seven-membered ring compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1985-10-02 EP disclosed